Related Experiment Video

Updated: Jun 13, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Retained sensitivity to cytotoxic pyrimidine nucleoside analogs in thymidine kinase 2 deficient human fibroblasts

Mia Bjerke1, Nicola Solaroli, Nicole Lesko

  • 1Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden.

Nucleosides, Nucleotides & Nucleic Acids
|April 15, 2010
PubMed

Insights

Thymidine kinase 2 (TK2) deficiency in fibroblasts did not alter sensitivity to pyrimidine nucleoside analogs. This suggests TK2 phosphorylation is less critical for the cytotoxic effects of these compounds compared to other kinases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Thymidine kinase 2 (TK2) is a mitochondrial enzyme crucial for phosphorylating nucleoside analogs.
  • These analogs are widely used in antiviral and anticancer therapies.
  • Understanding TK2's role is vital for optimizing drug efficacy and minimizing side effects.

Purpose of the Study:

  • To investigate the impact of TK2 deficiency on nucleotide metabolism.
  • To determine the role of TK2 in cellular sensitivity to cytotoxic nucleoside analogs.
  • To compare the importance of TK2 versus other deoxyribonucleoside kinases in drug response.

Main Methods:

  • Utilized a fibroblast cell line engineered for decreased TK2 activity.
  • Analyzed nucleotide metabolism in TK2-deficient cells.
  • Assessed cellular sensitivity to various pyrimidine nucleoside analogs.

Main Results:

  • TK2-deficient cells maintained sensitivity to all tested pyrimidine nucleoside analogs.
  • The study observed no significant alteration in nucleotide metabolism due to TK2 deficiency.
  • This indicates compensatory mechanisms may be active.

Conclusions:

  • TK2-mediated phosphorylation appears less critical for the cytotoxic effects of pyrimidine nucleoside analogs than previously thought.
  • Other deoxyribonucleoside kinases may play a more significant role in drug response.
  • Further research is needed to elucidate the complete network of nucleoside kinases and their contribution to drug efficacy.

More Related Videos

Immunofluorescent Detection of Two Thymidine Analogues (CldU and IdU) in Primary Tissue10:55

Immunofluorescent Detection of Two Thymidine Analogues (CldU and IdU) in Primary Tissue

Published on: December 7, 2010

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...